These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling. Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019 [TBL] [Abstract][Full Text] [Related]
7. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402 [TBL] [Abstract][Full Text] [Related]
8. Molecular markers and genetics in cancer development. Hormi-Carver K; Souza RF Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707 [TBL] [Abstract][Full Text] [Related]
10. TP53 gene mutations are rare in nondysplastic Barrett's esophagus. Novotna K; Trkova M; Pazdro A; Smejkal M; Soukupova A; Kodetova D; Smejkal P; Sedlacek Z Dig Dis Sci; 2006 Jan; 51(1):110-3. PubMed ID: 16416221 [TBL] [Abstract][Full Text] [Related]
14. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379 [TBL] [Abstract][Full Text] [Related]
15. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. Walch A; Mueller J; Höfler H; Werner M J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093 [No Abstract] [Full Text] [Related]
16. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566 [TBL] [Abstract][Full Text] [Related]
17. Early Barrett's carcinoma of the esophagus. Hölscher AH; Vallböhmer D; Bollschweiler E Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920 [No Abstract] [Full Text] [Related]
18. Strategies for molecular intervention in esophageal cancers and their precursor lesions. Schrump DS; Nguyen DM Dis Esophagus; 1999; 12(3):181-5. PubMed ID: 10631909 [TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
20. Aneuploidy mechanisms in human colorectal preneoplastic lesions and Barrett's esophagus. Is there a role for K-ras and p53 mutations? Giaretti W Anal Cell Pathol; 1997; 15(2):99-117. PubMed ID: 9413595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]